News
In early days, bioabsorbable stent rivals nonabsorbable devices
Late lumen loss with a new bioabsorbable drug-eluting stent is on par with nonabsorbable devices in early data.
News
Long-term BP reductions with renal denervation not race specific
Long-term blood pressure reductions in the Black patient cohort of the SYMPLICITY renal denervation trial challenge early results.
News
Causal AI quantifies CV risk, providing patient-specific goals
Causal artificial intelligence is showing how specific risk factors can be overcome to avoid cardiovascular events.
News
When intravascular imaging guides complex PCI, MACE risk is lowered
In stent placement for complex coronary lesions, intravascular imaging reduces events relative to angiography.
News
Transcatheter tricuspid valve repair effective and safe for regurgitation
In a randomized pivotal trial, a percutaneous repair of tricuspid valve regurgitation was effective and safe.
News
At 5 years, TAVI valves perform better than surgical ones
TAVR valves deteriorate less than surgical valves at 5 years in patients treated for severe aortic stenosis.
News
Risk of stent infection low, but may be underreported
The systematic review of coronary stent infections leads investigator to question whether they are underreported.
News
In weighing PCI vs. CABG for left main disease, diabetes matters
In patients with diabetes and left main artery disease, the risks of PCI and CABG are different when either can be used.
News
Drinking beet juice tied to reduced post-PCI restenosis
Dietary nitrate in the form of beet juice reduced restenosis after percutaneous interventions in a randomized trial.
News
New tool better estimates cardiovascular risk in people with lupus
A tool to estimate cardiovascular risk in systemic lupus erythematosus incorporates disease-specific variables.
News
PsA prediction tool approaches clinical utility
A tool to identify patients with psoriasis at high risk of psoriatic arthritis appears near to clinical application.
News
Two biomarkers identify high-risk lupus nephritis
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.
News
Biosimilars perform identically to originator biologics in natural experiment
A real-world analysis of the impact of biosimilar switches over 3 years of follow-up addresses the limitations of formal trials in assessing...
News
Elevated PCSK9 levels associated with psoriasis suggest new treatment target
A large population analysis implicates PCSK9 as a target in prevention of psoriasis.
News
After PCI, 1-month beats 12-month DAPT in high-risk patients
When dual was replaced by single antiplatelet therapy 1 month after PCI in Japanese patients, bleeding risk declined.